These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 28686059

  • 1. Household Diversion of Prescription Stimulants: Medication Misuse by Parents of Children with Attention-Deficit/Hyperactivity Disorder.
    Pham T, Milanaik R, Kaplan A, Papaioannou H, Adesman A.
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):741-746. PubMed ID: 28686059
    [Abstract] [Full Text] [Related]

  • 2. Physician practices to prevent ADHD stimulant diversion and misuse.
    Colaneri N, Keim S, Adesman A.
    J Subst Abuse Treat; 2017 Mar; 74():26-34. PubMed ID: 28132697
    [Abstract] [Full Text] [Related]

  • 3. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB, Walker DJ.
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [Abstract] [Full Text] [Related]

  • 4. Physician Training and Qualification to Educate Patients on Attention-Deficit/Hyperactivity Disorder Stimulant Diversion and Misuse.
    Colaneri N, Keim SA, Adesman A.
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):554-561. PubMed ID: 30124331
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of ADHD symptom malingering, nonmedical use, and drug diversion among college-enrolled adults with a prescription for stimulant medications.
    Ramachandran S, Dertien D, Bentley SI.
    J Addict Dis; 2020 Oct; 38(2):176-185. PubMed ID: 32242510
    [Abstract] [Full Text] [Related]

  • 6. Adolescent Patient Education Regarding ADHD Stimulant Diversion And Misuse.
    Colaneri N, Keim S, Adesman A.
    Patient Educ Couns; 2017 Feb; 100(2):289-296. PubMed ID: 27609322
    [Abstract] [Full Text] [Related]

  • 7. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.
    Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S.
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):21-31. PubMed ID: 18174822
    [Abstract] [Full Text] [Related]

  • 8. Stimulant Diversion Risk Among College Students Treated for ADHD: Primary Care Provider Prevention Training.
    Molina BSG, Kipp HL, Joseph HM, Engster SA, Harty SC, Dawkins M, Lindstrom RA, Bauer DJ, Bangalore SS.
    Acad Pediatr; 2020 Jan; 20(1):119-127. PubMed ID: 31185307
    [Abstract] [Full Text] [Related]

  • 9. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV, Wilens TE.
    J Clin Psychiatry; 2007 Jan; 68 Suppl 11():15-22. PubMed ID: 18307377
    [Abstract] [Full Text] [Related]

  • 10. Stimulant prescription cautions: addressing misuse, diversion and malingering.
    Rabiner DL.
    Curr Psychiatry Rep; 2013 Jul; 15(7):375. PubMed ID: 23712725
    [Abstract] [Full Text] [Related]

  • 11. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder.
    Babinski DE, Waxmonsky JG, Waschbusch DA, Humphery H, Pelham WE.
    J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):250-257. PubMed ID: 27991835
    [Abstract] [Full Text] [Related]

  • 12. Perspectives of US Adolescents on Diverted Stimulant Use.
    Hadler N, Strome A, Waselewski M, Herbert K, Harper C, Chang T.
    J Pediatr; 2021 Aug; 235():190-195. PubMed ID: 33862023
    [Abstract] [Full Text] [Related]

  • 13. Attention-Deficit Hyperactivity Disorder Stimulant Therapy and Prescription Drug Misuse During Transition to Young Adulthood.
    McCabe SE, Schulenberg JE, Wilens TE, Schepis TS, Werner KS, McCabe VV, Veliz PT.
    Psychiatr Serv; 2024 Jul 01; 75(7):622-629. PubMed ID: 38321920
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diversion of ADHD Stimulants and Victimization Among Adolescents.
    Epstein-Ngo QM, McCabe SE, Veliz PT, Stoddard SA, Austic EA, Boyd CJ.
    J Pediatr Psychol; 2016 Aug 01; 41(7):786-98. PubMed ID: 26590265
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Physician perceptions of the use of medications for attention deficit hyperactivity disorder.
    Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR.
    J Manag Care Pharm; 2003 Aug 01; 9(5):416-23. PubMed ID: 14613439
    [Abstract] [Full Text] [Related]

  • 18. Adolescents Treated for Attention-Deficit/Hyperactivity Disorder in Pediatric Primary Care: Characterizing Risk for Stimulant Diversion.
    Molina BSG, Joseph HM, Kipp HL, Lindstrom RA, Pedersen SL, Kolko DJ, Bauer DJ, Subramaniam GA.
    J Dev Behav Pediatr; 2021 Sep 01; 42(7):540-552. PubMed ID: 33908377
    [Abstract] [Full Text] [Related]

  • 19. Misuse of Methylphenidate.
    Clemow DB.
    Curr Top Behav Neurosci; 2017 Sep 01; 34():99-124. PubMed ID: 26695166
    [Abstract] [Full Text] [Related]

  • 20. Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance system.
    Cassidy TA, McNaughton EC, Varughese S, Russo L, Zulueta M, Butler SF.
    J Atten Disord; 2015 Apr 01; 19(4):275-83. PubMed ID: 23900405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.